Ellen Welch

This inventor holds 35 USPTO granted patents and 11 published patent applications, plus 5 CIPO patents and 9 EPO patents, primarily in Nonsense Suppression. Top assignees: Ptc Therapeutics, Inc., F. Hoffmann-La Roche Ag, Amgen Inc.. Active years: 2007-2023.

USPTO Granted Patents = 35 (Patent Applications = 11)

% Patents Active = 60.0

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 9 (Patent Applications = 15)

Average Co-Inventor Count = 5.1

ph-index = 9

Forward Citations = 229(Granted Patents)

Company Filing History:

35 out of 186

Ptc Therapeutics, Inc.

patents

6 out of 180

F. Hoffmann-La Roche Ag

where one patent can have more than one assignee

Years Active: 2007-2023

Loading Chart...

Areas of Expertise:

Spinal Muscular Atrophy

Nonsense Suppression

Pharmaceutical Compositions

1,2,4-Oxadiazole

Benzoic Acid

Epilepsy Treatment

Muscular Dystrophy

Small Molecules

Translation Termination

Cancer Treatment

Genetic Diseases

Assays

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11753407 - Compounds for treating spinal muscular atrophy (2023-09-12),

2. 10851101 - Compounds for treating spinal muscular atrophy (2020-12-01),

3. 10618877 - Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid (2020-04-14),

4. 10517853 - Methods for treating epilepsy (2019-12-31),

5. RE47689 - Compounds for treating spinal muscular atrophy (2019-11-04),

6. 10233161 - Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid (2019-03-19),

7. 9879007 - Compounds for treating spinal muscular atrophy (2018-01-30),

8. 9873677 - Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid (2018-01-23),

9. 9617268 - Compounds for treating spinal muscular atrophy (2017-04-11),

10. 9611230 - 1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease (2017-04-04),

11. 9586955 - Compounds for treating spinal muscular atrophy (2017-03-07),

12. 9399649 - Compounds for treating spinal muscular atrophy (2016-07-26),

13. 9376725 - Methods of screening for compounds for treating muscular dystrophy using human ALPHA7 integrin mRNA translation regulation (2016-06-28),

14. 9315467 - Compounds for nonsense suppression, and methods for their use (2016-04-19),

15. 9289398 - Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith (2016-03-22),

Title: Inventor Ellen Welch: Pioneering Innovations in Califon, NJ

Introduction: Ellen Welch is a visionary inventor based in Califon, NJ, known for her groundbreaking contributions to various industries.

Latest Patents: Ellen Welch holds several patents in the fields of sustainable energy, biotechnology, and consumer electronics, with her most recent patent focusing on eco-friendly packaging solutions.

Career Highlights: With a career spanning over two decades, Ellen Welch has established herself as a leading figure in the innovation landscape, receiving numerous accolades for her inventive spirit and problem-solving abilities.

Collaborations: Throughout her career, Ellen Welch has collaborated with top research institutions, universities, and companies to bring her ideas to life, fostering a culture of innovation and creativity in the process.

Conclusion: Ellen Welch's passion for innovation and dedication to creating a positive impact on society through her inventions make her a true trailblazer in the world of technology and beyond.